NEW YORK (GenomeWeb News) — Evotec Technologies has sold the “core” of its single molecule detection technology and transferred or licensed the related IP to Olympus, the company said today.
 
The move is in line with the Evotec division’s goal of focusing its business more on cell imaging and cell handling systems, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.